litlas
Log inCreate account

John C. Davis

Active 1952–2025

Also published as
John C Davis
73
Papers
22,750
Citations
62
h-index
70
i10-index

Citations

Citations per year for John C. Davis1966: 1 citations1967: 3 citations1968: 1 citations1969: 2 citations1970: 2 citations1972: 4 citations1973: 2 citations1974: 2 citations1975: 5 citations1976: 9 citations1977: 7 citations1978: 4 citations1979: 5 citations1980: 12 citations1981: 8 citations1982: 9 citations1983: 16 citations1984: 17 citations1985: 9 citations1986: 15 citations1987: 13 citations1988: 18 citations1989: 27 citations1990: 17 citations1991: 23 citations1992: 29 citations1993: 28 citations1994: 26 citations1995: 26 citations1996: 35 citations1997: 22 citations1998: 27 citations1999: 25 citations2000: 35 citations2001: 49 citations2002: 47 citations2003: 63 citations2004: 84 citations2005: 127 citations2006: 128 citations2007: 145 citations2008: 176 citations2009: 160 citations2010: 197 citations2011: 237 citations2012: 173 citations2013: 166 citations2014: 153 citations2015: 144 citations2016: 150 citations2017: 157 citations2018: 129 citations2019: 356 citations2020: 383 citations2021: 306 citations2022: 230 citations2023: 171 citations2024: 237 citations2025: 106 citations2026: 2 citations1971: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,436 citing papers, 20.8% of this breakdownUnited Kingdom: 551 citing papers, 8% of this breakdownGermany: 495 citing papers, 7.2% of this breakdownNetherlands: 376 citing papers, 5.4% of this breakdownFrance: 360 citing papers, 5.2% of this breakdownChina: 351 citing papers, 5.1% of this breakdownCanada: 345 citing papers, 5% of this breakdownItaly: 266 citing papers, 3.9% of this breakdownSpain: 204 citing papers, 3% of this breakdownAustralia: 190 citing papers, 2.8% of this breakdownBelgium: 147 citing papers, 2.1% of this breakdownSwitzerland: 130 citing papers, 1.9% of this breakdown
0%20.8%Other 29.6%

Institutions

Fields

  • Medicine53.3%
  • Computer Science10.3%
  • Environmental Science9.7%
  • Immunology and Microbiology7.6%
  • Earth and Planetary Sciences5.8%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Other8.5%

Topics

  • Spondyloarthritis Studies and Treatments9.8%
  • Rheumatoid Arthritis Research and Therapies8.1%
  • Geochemistry and Geologic Mapping3.7%
  • Systemic Lupus Erythematosus Research3.4%
  • Vasculitis and related conditions3.1%
  • Psoriasis: Treatment and Pathogenesis3.1%
  • Other68.8%

Coauthors

All papers

Open in search
  1. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

    Authors: Cédric Lukas, Robert Landewé, Joachim Sieper, Maxime Dougados, John C. Davis, Joseph M. Braun, S van der Linden, Désirée van der Heijde - Annals of the Rheumatic Diseases 2008 cited by 1,055

  2. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    Authors: Martín Rudwaleit, R. Landewé, Désirée van der Heijde, Joachim Listing, J. Brandt, Joseph M. Braun, R Burgos-Vargas, Eduardo Collantes‐Estévez, John C. Davis, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Irene E. van der Horst‐Bruinsma, Robert D. Inman, Muhammad Asim Khan, Marjatta Leirisalo‐Repo, S. van der Linden, Walter P. Maksymowych, Herman Mielants, Ignazio Olivieri, R D Sturrock, Kurt De Vlam, Joachim Sieper - Annals of the Rheumatic Diseases 2009 cited by 943

  3. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

    Authors: Kenneth Kalunian, Joan T. Merrill, Romeo Maciuca, Jacqueline McBride, Michael J. Townsend, Xiaohui Wei, John C. Davis, William P. Kennedy - Annals of the Rheumatic Diseases 2015 cited by 339

  4. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis

    Authors: John C. Davis, S Manzi, Cheryl Yarboro, Joan E. Rairie, Iain B. McInnes, D Averthelyi, Dominick Sinicropi, Victoria Hale, James E. Balow, H A Austin, Dimitrios T. Boumpas, John H. Klippel - Lupus 1999 cited by 233

  5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

    Authors: Désirée van der Heijde, Alan Kivitz, Michael Schiff, Joachim Sieper, Ben A. C. Dijkmans, Jürgen Braun, Maxime Dougados, John D. Reveille, Robert Wong, H. Küpper, John C. Davis - Arthritis & Rheumatism 2006 cited by 878

  6. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

    Authors: Peter A. Merkel, Gang Xie, Paul A. Monach, Xuemei Ji, Dominic J. Ciavatta, Jinyoung Byun, Benjamin D. Pinder, Ai Zhao, Jinyi Zhang, Yohannes Tadesse, David C. Qian, Matthew T. Weirauch, Rajan P. Nair, Lam C. Tsoi, Christian Pagnoux, Simon Carette, Sharon A. Chung, David Cuthbertson, John C. Davis, Paul F. Dellaripa, Lindsy Forbess, Ora Gewurz‐Singer, Gary S. Hoffman, Nader Khalidi, Curry L. Koening, Carol A. Langford, Alfred Mahr, Carol A. McAlear, Larry W. Moreland, Philip Seo, Ulrich Specks, Robert Spiera, Antoine G. Sreih, E. William St. Clair, John H. Stone, Steven R. Ytterberg, James T. Elder, Jia Qu, Toshiki Ochi, Naoto Hirano, Jeffrey C. Edberg, Ronald J. Falk, Christopher I. Amos, Katherine A. Siminovitch - Arthritis & Rheumatology 2016 cited by 178

  7. Statistics and Data Analysis in Geology

    Authors: Robert H. Shumway, John C. Davis - Technometrics 1987 cited by 4,776

  8. A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    Authors: John H. Stone, Gary S. Hoffman, Peter A. Merkel, Yuan‐I Min, Misty L. Uhlfelder, David B. Hellmann, Ulrich Specks, Nancy B. Allen, John C. Davis, Robert Spiera, Leonard H. Calabrese, Fredrick M. Wigley, N Maiden, R. Valente, John L. Niles, Kenneth H. Fye, Joseph W. McCune, E. William St. Clair, Raashid Luqmani, for the International Network for the Study of the Systemic Vasculitides (INSSYS) - Arthritis & Rheumatism 2001 cited by 466

  9. Introduction to statistical pattern recognition

    Authors: John C. Davis - Computers & Geosciences 1996 cited by 463

  10. Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE

    Authors: William P. Kennedy, Romeo Maciuca, Kristen Wolslegel, Wei Tew, Alexander R. Abbas, Christina Chaivorapol, Alyssa Morimoto, Jacqueline McBride, Paul Brunetta, Bruce C. Richardson, John C. Davis, Timothy W. Behrens, Michael J. Townsend - Lupus Science & Medicine 2015 cited by 157

  11. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

    Authors: John C. Davis, Désirée van der Heijde, Jürgen Braun, Maxime Dougados, John J. Cush, Daniel O. Clegg, Alan Kivitz, Roy Fleischmann, Robert D. Inman, Wayne Tsuji, for the Enbrel Ankylosing Spondylitis Study Group - Arthritis & Rheumatism 2003 cited by 763

  12. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    Authors: Rui Jin, Laura Diekman, John D. Reveille, Xiaodong Zhou, Matthew A. Brown, Evgeny A. Glazov, Ran Duan, Alison Dowling, Gethin Thomas, Paul Leo, Patrick Danoy, Anne-Marie Sims, Emma L. Duncan, Jacqueline Taylor, Tracey Doan, Linda A. Bradbury, Johanna Hadler, Karena Pryce, David M. Evans, Sue M Ring, Matthew A. Brown, Tugce Karaderi, Claire Farrar, David Harvey, B P Wordsworth, Louise Appleton, Jennifer J. Pointon, John C. Davis, R Mogg, Millicent Stone, Emma Pomeroy, Laurie Savage, Panos Deloukas, Leena Peltonen, Pamela Whittaker, Vasudev Kumanduri, Walter P. Maksymowych, Robert D. Inman, Millicent Stone - Nature Genetics 2010 cited by 668

  13. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

    Authors: Robert D. Inman, John C. Davis, Désirée van der Heijde, Laura Diekman, Joachim Sieper, Sung Il Kim, M. Mack, John Han, Sudha Visvanathan, Zhenhua Xu, Benjamin Hsu, Anna Beutler, Jürgen Braun - Arthritis & Rheumatism 2008 cited by 593

  14. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice

    Authors: Chang Li, Kevin A. Goncalves, Tamás Raskó, Amit Pande, Sucheol Gil, Zhinan Liu, Zsuzsanna Izsvák, Thalia Papayannopoulou, John C. Davis, Hans‐Peter Kiem, André Lieber - Blood Advances 2021 cited by 20

  15. Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)

    Authors: Philip Seo, Yuan‐I Min, Janet T. Holbrook, Gary S. Hoffman, Peter A. Merkel, Robert Spiera, John C. Davis, Steven R. Ytterberg, E. William St. Clair, W. Joseph McCune, Ulrich Specks, Nancy B. Allen, Raashid Luqmani, John H. Stone - Arthritis & Rheumatism 2005 cited by 204

  16. Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

    Authors: Jennifer D. Gorman, Kenneth E. Sack, John C. Davis - New England Journal of Medicine 2002 cited by 707

  17. ANCA Are Detectable in Nearly All Patients with Active Severe Wegener’s Granulomatosis

    Authors: Javier D. Finkielman, Augustine S. Lee, Amber M. Hummel, Margaret A. Viss, G.L. Jacob, Henry A. Homburger, Tobias Peikert, Gary S. Hoffman, Peter A. Merkel, Robert Spiera, E. William St. Clair, John C. Davis, W. Joseph McCune, Andrea K. Tibbs, Steven R. Ytterberg, John H. Stone, Ulrich Specks - The American Journal of Medicine 2007 cited by 292

  18. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

    Authors: Ravi Suppiah, Andrew Judge, R.N. Batra, Oliver Floßmann, Lorraine Harper, Peter Höglund, M K Javaid, David Jayne, Chetan Mukhtyar, Kerstin Westman, John C. Davis, Gary S. Hoffman, W. Joseph McCune, Peter A. Merkel, E. William St. Clair, Philip Seo, Robert Spiera, John H. Stone, Raashid Luqmani - Arthritis Care & Research 2011 cited by 177

  19. Electrical stimulation and denervated muscles after spinal cord injury

    Authors: Ashraf S. Gorgey, Subhalakshmi Chandrasekaran, John C. Davis, Ines Bersch, Gary Goldberg - Neural Regeneration Research 2020 cited by 65

  20. Using multiple logistic regression and GIS technology to predict landslide hazard in northeast Kansas, USA

    Authors: Gregory C. Ohlmacher, John C. Davis - Engineering Geology 2003 cited by 674

  21. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trial

    Authors: Kenneth Kalunian, John C. Davis, Joan T. Merrill, Mark C. Totoritis, David Wofsy, for the IDEC‐131 Lupus Study Group - Arthritis & Rheumatism 2002 cited by 335

  22. Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study

    Authors: Peter A. Merkel, Grace H. Lo, Janet T. Holbrook, Andrea K. Tibbs, Nancy B. Allen, John C. Davis, Gary S. Hoffman, W. Joseph McCune, E. William St. Clair, Ulrich Specks, Robert Spiera, Michelle Petri, John H. Stone - Annals of Internal Medicine 2005 cited by 307

  23. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

    Authors: John C. Davis, D M van der Heijde, J Braun, M Dougados, J Cush, D Clegg, R D Inman, A Kivitz, L Zhou, A Solinger, W Tsuji - Annals of the Rheumatic Diseases 2005 cited by 190

  24. Minimal Dissolved Oxygen Requirements of Aquatic Life with Emphasis on Canadian Species: a Review

    Authors: John C. Davis - Journal of the Fisheries Research Board of Canada 1975 cited by 578